A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma

• Vincent M DeStefano,
• Masayuki Wada,
• Kevin G Pinz,
• Rita Assi,
• Hongyu Zhang,
• Weijia Wang,
• Wenli Zhang,
• Darshi Shah,
• Yupo Ma,
• Huda Salman

Affiliations

Vincent M DeStefano

Research & Development Division iCell Gene Therapeutics Inc., Long Island High Technology Incubator Stony Brook New York USA

Masayuki Wada

Research & Development Division iCell Gene Therapeutics Inc., Long Island High Technology Incubator Stony Brook New York USA

Kevin G Pinz

Research & Development Division iCell Gene Therapeutics Inc., Long Island High Technology Incubator Stony Brook New York USA

Rita Assi

Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA

Hongyu Zhang

Department of Hematology Peking University Shenzhen Hospital Shenzhen China

Weijia Wang

Department of Advanced Diagnostic and Clinical Medicine Zhongshan People's Hospital Zhongshan People's Republic of China

Wenli Zhang

Department of Hematology Peking University Shenzhen Hospital Shenzhen China

Darshi Shah

Research & Development Division iCell Gene Therapeutics Inc., Long Island High Technology Incubator Stony Brook New York USA

Yupo Ma

Research & Development Division iCell Gene Therapeutics Inc., Long Island High Technology Incubator Stony Brook New York USA

Huda Salman

Brown Center for Immunotherapy Indiana University School of Medicine Indianapolis Indiana USA